Mee Ran Kim

No ORCID on file · 5 papers in corpus · active 2012-2018

Study types

  • article 4
  • other 1

Condition tags

  • endometriosis 3
  • adenomyosis 2
  • dysmenorrhea 1
  • chronic_pelvic_pain 1
article 2018
·doi:10.12891/ceog4116.2018

Objective: The aim of this study is checking the blood level of cadmium (Cd) and lead in the patients with endometriosis or uterine leiomyomas. Materials and Methods: A total of 100 patients who underwent surgery for gynecological disease i…

article 2018
Obstetrics & gynecology science ·doi:10.5468/ogs.2018.61.1.127

OBJECTIVE: We compared the expression levels of Müllerian inhibiting substance (MIS)/anti-Müllerian hormone type II receptor (AMHRII) in uterine myoma and adenomyosis to evaluate the possibility of using MIS/anti-Müllerian hormone (AMH) as …

other 2017
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2017.05.018

OBJECTIVE: Endometriosis is a multifactorial gynaecological disease in reproductive-age women. Endometriotic tissue is characterized by high prostaglandin levels and progesterone resistance. Human aldo-keto reductases (AKRs) convert progest…

article 2016
Yonsei medical journal ·doi:10.3349/ymj.2016.57.6.1531

An adenomyomectomy is a conservative-surgical option for preserving fertility. Conventional laparoscopic adenomyomectomies present difficulties in adenomyoma removal and suturing of the remaining myometrium. Robot-assisted laparoscopic surg…

article 2012
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2012-1538

CONTEXT: Müllerian inhibiting substance (MIS) is produced in Sertoli cells of fetal testis and causes regression of müllerian ducts in male embryos. MIS also can induce the cell cycle arrest and apoptosis in müllerian duct-derived tumors in…